Paul J Mulholland (Paul Mulholland)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Dna Methylation

Signaling Pathway

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

University College London

University College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University College London Sep 01 2009

United Kingdom

Honorary Senior Lecturer :: Cancer Institute

University College London Hospitals NHS Foundation Trust Apr 01 2007

United Kingdom

Consultant in Medical Oncology :: Oncology

Education History

University College London Apr 01 2001 - Feb 01 2005

United Kingdom

PHD :: Biology

University of Birmingham Sep 01 1998 - Aug 01 2000

United Kingdom

MSC :: Oncology

Publications

Vassilis Genoud, Ben Kinnersley, Nicholas F Brown, Diego Ottaviani, Paul J Mulholland
Therapeutic Targeting of Glioblastoma and the Interactions with Its Microenvironment. Cancers 15 (24) (2023)
Vassilis Genoud, Ben Kinnersley, Nicholas F Brown, Diego Ottaviani, Paul J Mulholland
Therapeutic Targeting of Glioblastoma and the Interactions with Its Microenvironment. Cancers 15 (24) (2023)
Kaspar Draaisma, C Mircea S Tesileanu, Iris de Heer, Martin Klein, Marion Smits, Jaap C Reijneveld, Paul M J Clement, Filip Yves Francine De Vos, Antje Wick, Paul J Mulholland, Martin J B Taphoorn, Michael Weller, Olivier Louis Chinot, Johan M Kros, Tina Verschuere, Corneel Coens, Vassilis Golfinopoulos, Thierry Gorlia, Ahmed Idbaih, Pierre A J T Robe, Martin J Van Den Bent, Pim J French
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Nicholas F Brown, Stasya M Ng, Claire Brooks, Tim Coutts, Jane Holmes, Corran Roberts, Leena Elhussein, Peter Hoskin, Tim Maughan, Sarah Blagden, Paul J Mulholland
A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol. BMC cancer 20 (1) (2020)